MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting

  • Silvia Pomella
  • , Matteo Cassandri
  • , Lucrezia D’Archivio
  • , Antonella Porrazzo
  • , Cristina Cossetti
  • , Doris Phelps
  • , Clara Perrone
  • , Michele Pezzella
  • , Antonella Cardinale
  • , Marco Wachtel
  • , Sara Aloisi
  • , David Milewski
  • , Marta Colletti
  • , Prethish Sreenivas
  • , Zoë S. Walters
  • , Giovanni Barillari
  • , Angela Di Giannatale
  • , Giuseppe Maria Milano
  • , Cristiano De Stefanis
  • , Rita Alaggio
    • Sonia Rodriguez-Rodriguez, Nadia Carlesso, Christopher R. Vakoc, Enrico Velardi, Beat W. Schafer, Ernesto Guccione, Susanne A. Gatz, Ajla Wasti, Marielle Yohe, Myron Ignatius, Concetta Quintarelli, Janet Shipley, Lucio Miele, Javed Khan, Peter J. Houghton, Francesco Marampon, Berkley E. Gryder, Biagio De Angelis, Franco Locatelli, Rossella Rota

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology